Zhejiang Starry Pharmaceutical Company is Pharmaceuticals in China that focus on Pharmaceutical Co Ltd business. Founded in 1997. They cover business area such as Zhejiang Starry Pharmaceutical Co Ltd, r&d, manufacture, marketing, active ingredient, intermediate X-CT non-ionic contrast agent series, Fluoroquinolones series.
1997
( 27 years old in 2024 )
Pharmaceutical Co Ltd
-
No. 1 Starry Road of Modern Industrial Centralization Zone
Zhejiang, Xianju 317300
China
Private
Zhejiang Starry Pharmaceutical Co Ltdr&dmanufacturemarketingactive ingredientintermediate X-CT non-ionic contrast agent seriesFluoroquinolones series
* We use standard office opening hours in near Zhejiang Starry Pharmaceutical Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Zhejiang Starry Pharmaceutical Company is Pharmaceuticals business from China that founded in 1997 (27 years old in 2024), Zhejiang Starry Pharmaceutical Company business is focusing on Pharmaceutical Co Ltd.
Zhejiang Starry Pharmaceutical Company headquarter office and corporate office address is located in No. 1 Starry Road of Modern Industrial Centralization Zone Zhejiang, Xianju 317300 China.
Zhejiang Starry Pharmaceutical Company was founded in China.
In 2024, Zhejiang Starry Pharmaceutical Company is currently focus on Pharmaceutical Co Ltd sector.
Above is snippet of Google Trends for "Pharmaceutical Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Zhejiang Starry Pharmaceutical Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
